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The first joint
meeting of
TROIKA and the Clinical Chairpersons
was held this month. The agenda for
these meetings will include issues
related to Medical Staff Development,
New Procedures/New Technologies,
and Medical Staff/Departmental
matters. We will be meeting on a
monthly basis to review these topics.
A seat is also to be given to the (when
identified) Senior Vice President for
Clinical Services.
The search for the Senior Vice
President for Clinical Services is
proceeding well. Three candidates
have been interviewed and several
CV's have been reviewed. We have
identified one individual to return for a
second interview in the near future.
The search for the Chairperson of
Surgery is also proceeding well. Many
potential candidates have been
identified and the committee, headed
by John VanBrakle, M.D., has been
impressed with the quality of the
interested ·physicians. Michael
Kaufmann, M.D., is chairing a
committee to search for the
Chairperson of the newly created
Department of Health Studies and
Community Health. This new
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department is an amalgam of the
Research Department and the
Community Health Department. A
consultant, Sanford Schwartz, M.D.,
from the University of Pennsylvania,
an acknowledged expert in this field
and former President of the American
Federation of Clinical Research, will
be paying an on-site visit to advise us
regarding the structure of the
department. Finally, Lou Liebhaber
began his duties as COO on July 11.
Please join me in welcoming Lou to
the Lehigh Valley Hospital.
As part of the Functional Plan,
ExpressCare opened in the Emergency
Department at Cedar Crest.
ExpressCare began operations over the
July 4th weekend, and 95 patients were
evaluated. Also, the Mother-Baby
Unit opened on the 4th floor at 17th &
Chew. I encourage all to visit this
significant advance in our OB
Department.
As we have heard at our departmental
meetings, the new Critical Care
Structure, with divisions in the
Department of Medicine and the
Department of Surgery will become
operational in September. At this
time, 24 hour in-house coverage for
medicine as well as the surgical critical
care patients will begin.
Continued on Page 2

Continued from Page 1

I recommend that all IPA members
revi~w th; •:ext Managed Care UpdoJe
for 1mpor. · news regarding network
developmcm in the Hazleton area.

At. the July Board of'""; ,.;;tees meeting,
we learned that HC4 w: ii be reviewing
the DRG of Acute Myocardial
In~arction. A task force is currently
bemg developed.· Also, at the Board of
Trustees meeting, the Functional Plan
as we described in the last newsletter '
.
'
was unammously
approved.

1fi:;-A. Candio,

Site and Facilities Update

Lithotripsy Area to Expand

Best wishes,
M.D.
President, Medical Staff

-----------------------Cedar Crest·& 1-78
ExpressCare Now Avallable
Beginning July 1, emergency treatment
for minor illness or injury was made
available in a new division of the
Emergency Department.
ExpressCare is now available from 11
a.m. to 9 p.m., seven days a week, in
a four-bay treatment setting that
adjoins the registration area for
ambulatory patients.

On July 5, construction began on an
extension of the lithotripsy area
adjacent to the shock/trauma unit. A
dock will also be added to facilitate
transport of the portable lithotripter.
During this project, traffic at the rear
of the hospital will be reduced to a
single lane.

Administrative Services Relocation

The telephone number for ExpressCare
at Cedar Crest & I-78 is 402-1200.

Administrative offices adjacent to the
lobby will be relocated to an
administrative suite for senior
management on the third floor of the
Anderson Wing. The administrative
suite is now under construction and
scheduled for completion in late July.
The Board of Trustees conference
room will be relocated to this area as
well.

Radiology Adding Angiography

OR Scheduling to Relocate

ExpressCare occupies space that
previously housed offices for Medical
Staff Services.

Room
A second angiography room is being
added to the Radiology Depar.ment ir;
space previously occupied by a special
procedures room. The project will be
completed in early September.

)

OR Scheduling, which currently
occupies space in the nursing annex off
the main lobby, will be moving to
2024 Lehigh Street in mid-July.
Continued on Page 3
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Physicians, Staff Relocate
The following individuals have
relocated to the Department of
Medicine, Cedar Crest & I-78:
• Yehia Y. Mishriki, M.D.~ General
Internal Medicine, 402-8275
e Mark D. Kelley, M.D., General
Internal Medicine, 402-8275
• Gina Karess, M.D., General Internal
Medicine, 402-8275
• Jenni Levy, M.D., General Internal
Medicine, 402-8275
• Mary Lou Cressman, Administrative
Secretary, 402-8275
• Mary Ann Gergits, R.N., Research
Nurse Coordinator, has relocated to the
John and Dorothy Morgan Cancer
Center, and may be reached at
402-0544.

• Mary A. Swierczynski, R.N.,
Program Manager, Helwig Diabetes
Center and Endocrine Testing Station,
has moved to the Department of
Medicine, 17th & Chew, and may be
reached at 402-2957.
Cancer Center to House Offices
Work continues on the fourth floor of
the John and Dorothy Morgan Cancer
Center which will house new offices
for Human Resources, Legal Services/
Risk Management, Integrated Quality
Assessment/Resource Utilization
Management (IQA/RUM), the
Information Services Training Room,
and the Credit Union. In addition, the
third floor of the Cancer Center is
being finished for new physician
offices.

Occupancy is expected by early
August. Eventually, the Cancer Center
will house many of the departments
which now occupy the trailers at Cedar
Crest & I-78 as well as other
consolidated. departments.

New Numbers for Legal Services/
Risk Management
Although they will continue to operate
at their current location until August,
Legal Services/Risk Management have
already been assigned new telephone
extensions.
The new telephone number for Risk
Management is 402-5210. The
members of the staff include:
Georgene Saliba, Director, Risk
Management
Francine Miranda, Risk Manager
Rosemary Cerimele, Assistant Risk
Manager
Anthony Tarantino, Systems
Coordinator
Shirley Egan, Senior Secretary
The new telephone number for Legal
Services is 402-5215. Members of the
staff include:
Janine Fiesta, Esq., Vice President
Glenn Guanowsky, Staff Attorney
Brenda Troxell, Administrative
Secretary

Relocation of Transcription Services
On June 24, Medical Transcription
Services relocated to a new suite within
1251 S. Cedar Crest Boulevard. The
new mailing address for Medical
Transcription Services is 1251 S.
·
Cedar Crest Boulevard, Suite 308C.
Continued on Page 4
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17th & (, ew
Rehabilitative Services Relt,

New Location for Dental Service
~e

Having passed inspection by the
Division of Hospitals and the Life
Safety Division of the State
Department of Health, the fifth floor
Tower is now occupied by Physical
and Occupational Therapy. These
departments can now be reached at
402-2828. The rehabilitative services
will adjoin the transitional, or subacute care, unit now under review by
the Pennsylvania Department of
Health.

Renovations are underway on 1N for
the Dental Service's new dental clinic,
laboratories, ::nd administrative
functions.
Renovations to Begin for Ambulatory
Surgery
Renovations to the second floor Tower
are underway for an ambulatory
surgery suite that will adjoin the
Operating Room suites. The OR suites
are also scheduled for renovations
during the same time frame.

Speech Pathology Relocates

HealtbPage to Relocate

Speech Pathology at 17th & Chew has
been relocated from the second to the
fifth floor. The telephone number
remains the same, 402-2544. Mail
forwarded to the department should be
sent to Speech Pathology, 17 - Fifth
Floor.

HealthPage will move from its Linden
Street location to 2024 Lehigh Street in
late July.

Changes to Medical Staff Bylaws
Courtesy staff physicians are reminded
of the recent Medical Staff Bylaws
changes which affect the level of
activity you may have at Lehigh Valley
Hospital. Those ~hanges are as
follows and have been bolded for your
review. The remainder of the article is
also important and should be reviewed.
1. The Courtesy Staff shall be
appropriate for those
practitioners who have no more
than twelve (12) patient

contact~·

annually except for
meml>+ ,: of those deparbnents
which specify a different and
lesser annual limitation as
delineated within the rules
and regulations of those
departments. This number
will apply to practitioners
regardless if they are engaged
in solo practice or a group
practice affiliation.
Continued on Page 5
Page 4
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(a)

(b)

The period for tracking
the number of patient
contacts shall extend
from July 1 through
June 30.
Department
Chairpersons shall have
the authority to modify
the annual limitation of
patient contacts for
Courtesy Staff
members within their
Departments in
accordance with the
needs and resources of
that Department. Such
limitation, if different
than the twelve (12)
stated above, must be
delineated within the
Department's Rules
and Regulations, which
are subject to annual
approval by the
Medical Executive
Committee.

2. Movement to ... category.

3. With the exception of the
Bylaws Committee, the Medical
Executive Committee and the
Credentials Committee,
Courtesy Staff members may
serve on Medical Staff
committees. Courtesy staff
members may not hold an office
of the Medical Staff or vote at
general or special Medical Staff
meetings and shall participate in
the quality assessment activities
as required of the Medical
Staff.
4. As determined by need, will
provide on-call consultation
coverage in the Emergency
Department, upon assignment
by ·the appertaining department
chairperson.

Code Blue Coverage at 17th & Chew
On June 24, the Medical Teaching
Service at 17th & Chew moved to
Cedar Crest & I-78. Due to this
move, immediate physician response
and subsequent care at 17th & Chew
will be handled, in the following
manner:

1. Physician Response
Weekdays (Monday through Friday)

o 8 a.m. to 5 p.m.
• CRNA will respond to all
codes.
• Anesthesiologist will respond
unless there is a code
simultaneously in the O.R.
Anesthesiologist will come to
floor as soon as situation in
O.R. is stabilized.
Continued on Page 6
Page 5
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• Page operator will also call
Medical Clinic from 1 to 5 p.m.
(Monday, Tuesday, Thursday,
Friday) and Surgical Clinic
from 1 to '5 p.m. (Wednesday)
for resident assistance with
codes.
• Any physician (attending or
resident) with ACLS training
should respond to open voice
page.
o 5 p.m. to 8 a.m.
• ··1edical resident will respond
to Code Beeper as usual.
Weekends (5 p.m. Friday to 8 a.m.
Monday)

• Medical re:·i dent will respond
to Code Beeper as usual.

2. Stabilization
Patient will be stabilized on the
floor and then transferred to the
Emergency Room for transfer to
Cedar Crest & I-78.

3. Transfer to Cedar Crest & 1-78
• Emergency Medicine physician
and personnel in Emergency Room
will make appropriate afra.ngements
for transfer.
• Emergency Medicine physician at
17th & Chew will assume medical
command for transfer.

Peripherally Inserted Central Catheters
Peripherally Inserted Central Catheters
(PICC) are now available and offer an
alternative method of vascular access
for short and intermediate (up to one
year) tht:rapy for certain patient
populations. This catheter may be
appropriate for patients who will
require IV therapy for at least five
days for:
• antibiotics
• hydration
• pain management
• antivirals
• chemotherapy
• nutritional support
• biologic response modifiers

required for successful placement. The
catheter may also be used to draw lab
specimens if a size fr. 4 or 5 is in
place. These catheters can be
successfully managed in the home. In
addition, since the catheter is made of
soft, biocompatible silicone, the risk of
thrombosis and phlebitis is minimized.
A core group of nurses have received
certification and education in PICC line
insertion. The team provides 24-hour
continuous beeper coverage to be
available to the staff for insertions or
problem solving.
.:.ontinued on Page 7

Early intervention of PICC candidates
is desirable since a suitable vein is
Page 6
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f you have a patient who would
nefit from a PICC line, please
onsult the PICC Team via the page
rator at 402-8999 or physician
rder sheet. A team member will.
sess the patient and discuss the case
ith the ordering physician BEFORE
e PICC is inserted.

If you have any questions or concerns
regarding this issue, please contact the
PICC Resource Team at 402-8999. An
eight-minute video detailing the
procedure is also available through the
team.

ractice Environment Project in Progress
ternal and external sources are
using changes in the management
d delivery of patient care services at
high Valley Hospital. Several
atient care units are implementing a
ollaborative practice model by
tilizing clinical paths, patient-focused
e is being introduced, new roles for
upportive personnel are being
xamined, and departments are striving
o achieve quality customer services in
cost-effective manner. These
hanges in the way services are
elivered are designed to improve the
fficiency and effectiveness of patient
. To assure the attainment of these
utcomes and to understand the factors
at are effecting the way employees at
high Valley Hospital do their work,
e Practice Environment Project (PEP)
been initiated. The purpose of this
roject is to provide an assessment of
e delivery of services within Lehigh
alley Hospital and to put into place a
echanism in which the delivery of
rvices is enhanced via the
anagement of the barriers that impede
e delivery of those services.
EP is being implemented house-wide.
wo subprojects have been
mplemented to collect the data.

Project 1 focuses on the collection of
two types of quantitative data: 1)
employees are completing job
satisfaction surveys, and 2) customers ·
of the various departments are
reporting their satisfaction with
services. The nursing staff completed
this information last summer and will
be asked to provide similar data again
this summer for a comparative
analysis. Over the summer, these
surveys are being circulated to most
departments.
Physician input as internal customers
on patient care units has been sought.
As part of the unit-based analysis,
Directors of the patient care units
identified specific physician unit
admitters. These physicians were
mailed surveys related to their
perceptions of the quality of nursing
care and collaboration with nurses on
the specified unit. A total of 766 sets
of questionnaires were mailed to
identified physicians; 190 returned the
questionnaires; 173 sets of
questionnaires were complete and
usable, with a response rate of 22.5%.
Continued on Page 8
Page 7
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Project 2 is composed of two phases:
Phase 1 focuses on the collection of
qualitative data obtained via focus
groups with staff and with management
teams.
The purpoSe of the focus groups is to
identify those factors which effect the
staff's ability to provide quality patient
care and customer services. Data
collected from the focus groups are
summarized in a report that serves as
the foundation for action plans. Focus
groups have been completed on ~
nursing units and a~·, underway m
other departments. , \S a result of
summary reports from the nursing
units, a list of global issues have been
identified. These issues are being
addressed at the department level and
will be addressed via interdepartmental
action plans, as is appropriate.
Phase 2 centers on the development,
implementation and evaluation of
action plans that are based on the
issues identified in the focus groups.

The action plan is a collaborative effon.
between staff and management. The
plans are recorded and evaluated
annually. The plan is then to be
revised and updated each year. This
process fosters communication between
staff and management, provides a
mechanism for identifying and
managing departmental issues with
staff input, and facilitates problemsolving between departments on
common issues.
Updates about PEP, including the
status of the project, results of
physician surveys and global results of
the surveys, will be presented in future
editions of Medical Stoff Progress

Notes.
For more information about PEP,
contact Cecelia Gatson Grindel, R.N.,
Ph.D., Office of Professional
Development, at 402-1704.

New Library Circulation
Procedure
Effective July 1, the Library began
using its computer system to check out
materials to users. To use the library,
your hospital photo I.D. card w~ .
serve as your library card, and 1t will
be necessary to bring it with you each
time you use the library.

Please allow extra time for the library
to gather and input the data.
Your patience and cooperation is very
much appreciated by the library staff
during this transition period.
Continued on Page 9

Standard registration information must
be entered into our computer system
the first time you check out materials.
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Recent Acquisitions
17th & Chew
Dershewitz. Ambulatory Pediatric Care.
2nd eel. Lippincott, 1993.
Sabbagba. Diagnostic Ultrasound Applied to
Obstetrics and Gynecology. 3rd eel.
Lippincott, 1994.
Lee. Atlas of Gynecologic SUI'IJery.
Saunders, 1992.
Fisher. Modification ~d Preservation of

Existing Dental Restorations. Quintessence,
1987.

Cedar Crest & 1-78
Muma. HIV Manual for Health Care
Professionals. Appleton & Lange, 1994.
Tobin. Principles and Practice of
Mechanical Ventilation. McGraw Hill, 1994.
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Coding
The following continues the list of
common conditions which are not
consistently documented in the medical
record.
DIAGNOSES
Chronic Obstructive Lung Disease (COPD)
Bronchitis with. COPD
Asthma with COPD
Emphysema
Respiratory Failure
Post Operative (period) Atelectasis

Accurate documentation enables
accurate data collection and optimal
reimbursement.

Baum. Textbook of Pulmonary Diseases Volwne 1 and 2. Sth ed. Little, Brown and
Co., 1994.
Cob~. Mu~of~cand

Reconstructive SUI'IJery- Volwne 1, 2 and 3.
Little, Brown and Co., 1994.
Gerteis. Through the Patient's Eyes. JoseyBass Inc., 1993.

Also, library evaluation forms were
distributed at the General Medical Staff
meeting on June 13.. If you have not
already returned your completed form
to the library, please do so. If you
need a form, please contact the library
at 402-8410.

Your input is invaluable in helping the
library identify areas for improvement
and for future development.

Closing at 17th & Chew
During OtT-Shift Hours
Beginning July 16, the Medical Record
Department at 17th & Chew will be
closed from Midnight to 7 a.m.,
Monday through Friday, and from 3:30
p.m. to 7 a.m., Saturday and Sunday.
The reduction in hours has been
brought about by the shifting of some
services to Cedar Crest & I-78 and
reallocating staff to that site.

If you have any questions regarding

this change, please contact Zelda
Greene, Director of Medical Records,
at 402-8330.

Thank you for your cooperation in this
matter.
Page 9

News from Research
Research Advisory
.
Committee - Request for
Proposals ·
The Research Advisory Committee
(RAC) meets bi-monthly to review
clinical/epidemiological research
proposals (requests for funding)
submitted by the Medical and
Professional staff of Lehigh Valley
Hospital.
All proposals must be submitted to the
Research Department for review three
weeks before the next scheduled RAC
meeting. The next meeting of the
RAC is August 17. All proposals
submitted by July 27 will be reviewed
by the Research Department before
being placed on the RAC agenda.
For more information or proposal
guidelines, contact James F. Reed ill,
Ph.D., Director of Research, at
402-8889.

Call fo: Abstracts

• The Eastern -\ssociation for Surgery·
of Tr;:·.~ma for the Annual Meeting to
be held on January 11, 1995 in
Sanibel, Fla. Submission due date is
August 5, 1994.
• Falk - IBD for the IBD, New
De ~ments and Standards to be held
on 1.~-..~vember. 1 · 1994 in Halle,
Germany. Subi:.~ssion due date is
August 31, 1994.
• The Institute of Applied Physiology
in Medicine for the 1995 Cerebral
Hemodynamics Symposium to be held
on February 7, 1995 in Charleston,
SC. Submission due date is October 7,
1994.
• The Society of Critical Care
Medicine for the 24th Educational &
Scientific Symposium to be held on
January 31, 1995 in San Francisco,
Calif. Submission due date is
September 1, 1994.
For instructions, forms, and further
information, please contact Kathleen
Moser in the Research Department at
402-8747.

A call for abstracts has been issued by
the following organizations:
• The American Association of
Neurological Surgeons for the Annual
Meeting to he held on Apri122, 1995
in Orlando. Fla. Submission due date
is August 18, 1994.
• The American College of Cardiology
for the 44th Annual Scientific Session
to be held on March 19, 1995 in New
Orleans, La. Submission due date is
September 9, 1994.
Page 10

Congratulations!
At the meeting of the Pennsylvania
State University College of Medicine
Appointments and Promotion and
Tenure Committee on May 4, the
following faculty appointments were
announced:
Robert V. Cummings, M.D.,
Professor of Clinical Obstetrics and
Gynecology and Associate Chair
John P. Fitzgibbons, M.D., Professor
of Medicine and Associate Chair
Michael W. Kauffman, M.D.,
Associate Chair and Professor of
Clinical Psychiatry
Stephen K. Klasko, M.D., Assistant
Professor of Clinical Obstetrics and
Gynecology
Brian. W. Little, M.D., Ph.D,
Assoc1ate Professor of Pathology
Ronald A. Lutz, M.D., Clinical
Associate Professor of Emergency
Medicine
Alphonse E. Maffeo, M.D., Clinical
Associate Professor of Anesthesia and
Associate Chair
William L. Miller, M.D., Associate
Professor of Family and Community
Medicine
Gary G. Nicholas, M.D., Professor of
Surgery
Walter J. Okonski, M.D., Clinical
Associate Professor of Surgery
Mark A. Osborne, M.D., Associate
Chair and Clinical Associate Professor
of Radiology
Victor R. Risch, M.D., Associate
Chair and Associate Professor of
Clinical Radiology
John J. Shane, M.D., Clinical
Professor of Pathology
Richard H. Snyder, M.D., Associate
Professor of Clinical Medicine
Elliot J. Sussman, M.D., Professor of
Medicine

John D. VanBrakle, M.D., Associate
Professor of Clinical Pediatrics and
Associate Chair
Headley S. White, Jr., M.D., Clinical
Associate Professor of Family and
Community Medicine
George F. Carr, D.M.D.,
prosthodontist and Vice Chairperson,
Department of Dentistry, was elected
President-elect of the Pennsylvania
Prosthodontic Association at its annual
meeting held June 10 and 11 in State
College, Pa.
Harold Kreithen, M.D., allergist, was
recently honored by the Pennsylvania
Allergy Association at their annual
June meeting in Hershey. Dr.
Kreithen received a special award
recognizing his outstanding
contributions to the field of allergy.

David Meir-Levi, D.O., cardiathoracic surgeon, was recently notified
by the American Osteopathic Board of
Surgery that he successfully completed
the required examination and has been
recommended for certification in
Thoracic Cardiovascular Surgery.
Peggy E. Showalter, M.D.,
psychiatri.st, was recently informed by
the Amencan Board of Psychiatry and
Neurology that she successfully passed
the examination for certification in the
medical subspecialty of Psychiatry with
Added Qualifications in Geriatric
Psychiatry.

Kenneth J. Zemanek,
M.D. '
.
psychiatrist, was recently informed by
the American Board of Psychiatry and
Neurology that he successfully passed
the examination for certification in the
medical subspecialty of Psychiatry with
Added Qualifications in Geriatric
Psychiatry.
Page 11

Publications, Papers and Presentations
Geof'le F. Carr, D.M.D.,

Scott D. Croll, M.D., former Chief

prosthodontist and Vice Chairperson,
Department of Dentistry, presented
Creatin& the Third Dentition with
Dental Implants to the Implant
Professional Study Club at the Adams
Mark Hotel, Philadelphia, Pa., on June
10. In addition, Dr. Carr presented
Biomechanics of Dental Implants as
the keynote speaker for the
Pennsylvania Prosthodontic
Asso-:iations annual meeting in State
Colkge, Pa., on Jun~ 11.

Surgical Resident, 1993-1994,
presented The Role of Maanetic
Resonance Imaging in the Diagnosis
of Osteomyelltis in Diabetic Foot
Infections at the eighth annual meeting
of the Eastern Vascular Society and the
Academy of Medicine held in
Montreal, Quebec, Canada in May.
The paper was co-authored by Dr.
Nicholas, Mark A. Osborne, M.D.,
Chairperson, Department of
Radiology/Diagnostic Medical
Imaging, Stuart A. Jones, M.D.,
Chief, Division of Nuclear Medicine,
and Thomas Wasser, M.Ed. of the
Research Department.

Clark D. Gerhart, M.D., Chief
Surgical Resident, and Gary G.
Nicholas, M.D., Program Director of
the General Surgery Residency, are coauthors of the paper, Predictive Model
for Colonic Ischemia Following
Abdominal Aortic Aneurysm Repair,
which was published in the April issue
of Vascular Surgery. James F. Reed
m, Ph.D., Director of Research, was
also co-author.

Michael W. Kaufmann, M.D.,
Chairperson, Department of
Psychiatry, recently presented Grand
Rounds at Miner's Memorial Hospital.
His topic was The Future of Mental

Health.
Peter A. Keblish, M.D., Chief,

Dr. Nicholas, along· with Dr. Reed and
David J. Musser, M.D., former Chief
Surgical Resident, 1993-1994, are
authors of the paper, Death and

Adverse Cardiac Events After
Carotid Endarterectomy, which was
recently published in the Journal of
Vascular Surgery.
Dr. Musser, Richard C. Boorse,
M.D., general surgeon, Fred Madera,
M.D., Surgical Resident, and Dr. Reed
recently had their paper, Laparoscopic
Colectomy: At What Cost, published
in Surgical Laparoscopy and

Division of Orthopedic Surgery, was
invited to Toronto, Canada to share his
expertise with unicompartmental knee
arthroplasty and specifically the DePuy
LCS knee at the Orthopedic and
Arthritis Hospital. Dr. Keblish gave a
presentation on LCS Clinical
Experience. In addition, Dr. Keblish
was invited to give a presentation in
Seville, Spain. The presentation was
titled, Alternative F1xation for

Unicompartimental Prosthesis.
Continued on Page 13

Endoscopy.
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Steven J. Lawrence, M.D.,
orthopedic surgeon, recently had his
manuscript, Management of the
Adult, Spastic, Equinovarus Foot
Deformity, published in Foot and
Ankle Inte17Uitional, June 1994.
Michael J. Botte, M.D., of the UCSD
Medical Center, San Diego, Calif, is
co-author.

Glen L. Oliver, M.D., ophthalmologist, co-authored an article which
appeared in the June, 1994 issue of
Archives of Ophthalmology. The
article, Recovery of Useful Vision
After Presumed Retinal and
Choroidal Toxic Effects From
Gentamicin Administration, reports a

case of Gentamicin choroidal and
retinal toxicity with recovery of useful
vision. Recovery of useful vision is
very rare following Gentamicin
toxicity.

Peggy E. Showalter, M.D.,
psychiatrist, presented Alcohol Level
at Head Injury and Subsequent
Psychotropic Treatment during
Trauma Critical Care at the annual
meeting of the American Psychiatric
Association in May. Co-authors
include Wayne E. Dubov, M.D.,
physiatrist; Maria C. Barr, Pharm.D.,
pharmacist; Michael Rhodes, M.D.,
Chief, Division of Trauma; Jyh-ming
Sun, B.S., former Pool Trust summer
intern; and Thomas Wasser, M.Ed.,
from the Department of Research.

Upcoming Seminars, Conferences and Meetings
Regional Symposium Series VI

Psychiatric Grand Rounds

Legal Update for Physicians: Risks
of Managed Care versus
"Unmanaged" Care will be presented
on Wednesday, August 24, from 8:30
a.m. to 12:15 p.m., in the Auditorium
of Lehigh Valley Hospital, Cedar Crest
& 1-78.

Inhibited Sexual Desire will be
presented by Gerald Weeks, Ph.D.,
Director of Training, Marriage Council
of Philadelphia, Division of Family
Study, University of Pennsylvania,
Department of Psychiatry, Clinical
Associate Professor of Psychology,
Department of Psychiatry, University
of Pennsylvania School of Medicine,
on Thursday, July 21, from noon to 1
p.m., in -the Auditorium of Lehigh
Valley Hospital, 17th & Chew. As
lunch will be served, pre-registration is
requested.

Physicians and other health care
professionals interested in legal issues
will benefit from the program.
At the completion of this program,
participants should be able to
identify managed care liability issues,
and describe malpractice and risk
management principles.

For more information or to register,
contact the Department of Psychiatry at
402-2810.

F9r more information, contact Human
Resource Development at 402-4609.
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• For Sale or Lease-- Springhouse
Professional Center, 1575 Pond Road.
Ideal for physician's office.
Approximately 2,500 sq. ft.
• For Sales or Lease -Medical/Professional three-story office
building at 1730 Chew Street,
Allentown. Excellent condition with
recent renovations. Approximately
6,800 sq. ft. for single or multiple
specialty practice. Includes long-term
parking lease at Fairgrounds.
Potential telephone and dictations
systems.
• For Sale -- Office building at
Northeast corner of 19th and Turner
Streets in Allentown. Upper level2,400 + sq. ft., large waiting room,
two large consultation rooms, five
exam rooms, etc. Lower level2,300 + sq. ft. Parking lot for 16
cars.
• For Lease -- Office to sublet on
Monday, Tuesday, Thursday, and
Friday. 950 sq. ft. Common waiting
area. Lakeside Professional Building,
Quakertown.
• For Lease-- Large, newly
remodeled, completely furnished
medical office space available- for
subleasing/time share at Cedar Crest
Professional Park. Top of the line
telephone system. Transcription and
computer system with electronic
billing available.

• For Lease -- Medical-professional
office spacf ':'Jcated on Route 222 in
Wescosvilk. Two 1,000 sq. ft.
offices avaitc.ble or combine to form
larger suite.
• For Leas£· ... Medical office space
located in· P<: .achtree Office Plaza in
Whitehall. One suite with 1,500 sq.
ft. (unfinished -allowance available),
and one 1,000 sq. ft. finished suite.
• For Lease -- Specialty practice timeshare space available in a
comprehensive health care facility.
Riverside Professional Center, 4019
Wynnewood Drive, Laurys Station.
Half- or full-day slots immediately
available.
·
• For Lease -- Professional office
space available in an established
psychology and psychotherapy
practice at 45 N. 13th Street,
Allentown. Large, warm Victorian
building in a relaxed atmosphere.
Secretary and billing available and
included in some leases. Furnished or
unfurnished full offices and sublets
available. Utilities included.
For more information or for assistance
in finding appropriate office space to
meet your needs, contact Joe Pilla,
Physician Relations Rep, at 402-9856.

• For Lease - Slots are currently
available for the Brown Bag suite at
Kutztown Professional Center. Ideal
for satellite location.
• For Lease -- Several time slots are
available in the medical office building
on the campus of Gnaden Huetten
Memorial Hospital in Lehighton.
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WHO'S NEW
The Who's New section of Medical
Stqff Progress Notes contains an
update of new appointments, address
changes, newly approved privileges,
etc. Please remember that each
department or unit is responsible for
updating its directory, rolodexes, and
approved privilege rosters.

Medical Staff
Appointments

Ellen M. Field-Munves, MD
(solo)
2045 Westgate Drive
Suite 102
Bethlehem, PA 18017-7498
(610) 691-6222
Department of Medicine
Division of Rheumatology
Provisional Referring
Marna R. Greenberg, DO
Emergency Care Associates of
Allentown
(Dr. Lutz)

Lori A. Barnett, DPM
(solo)
1040 Chestnut Street
Emmaus, PA· 18049-1903
(610) 965-8003
Department of Surgery
Division of Orthopedic Surgery
Section of Podiatry
Provisional Courtesy

Pragnesb A. Desai, DO
(solo)
1422 Hamilton Street
Allentown, PA 18102-4220
(610) 435-2261
Department of Surgery
Division of Urology
(limited to Lithotripsy and related
privileges)
Provisional Courtesy
Robert J. Ecbenberg, MD
(Hospital- Clinic)
826 Delaware ,Avenue
Bethlehem, PA 18015-1149
(610) 868-0381
Department of Obstetrics and
Gynecology
Division of Primary OB/GYN
Provisional Active

1503 N. Cedar Crest Blvd.
Allentown, PA 18104-2310
(610) 432-7094
Department of Emergency Medicine
Division of Emergency Medicine
(with referring privileges in Family
Practice)
Provisional Active
Randy Jaeger, MD
Lehigh Valley Orthopedics
(Dr. Anson)

1401 N. Cedar Crest Blvd.
Allentown, PA 18104-2394
(610) 821-4848
Department of Surgery
Division of Orthopedic Surgery
Provisional Active

Robert A. Matta, DO
(Richard Snyder, DO)

827 W. Wyoming Street
Allentown, PA 18103-3961
(610) 435-8643
Department of Family Practice
Provisional Referring
Continued on Page 16
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John S. Stevens, Jr., DO
Wescosville OB/GYN Associates
(Dr. Gene Miller)

682 N. Brookside Road
Wescosville, PA 18106-9708
(610) 398-1177
Department of Obstetrics and
Gynecology
Division of Primary OB/GYN
Provisional Courtesy

Thomas A. Ward, MD
Lehigh Valley Orthopedics
(Dr. Anson)

1401 N. Cedar Crest Blvd.
Allentown, PA 18104-2394
(610) 821-4848
Department of Surgery
Division of Orthopedic Surgery
Provisional Referring

Change of Status
Richard J. Morse, MD
(Lehigh Valley Pediatric Associates- Dr. Morffi)

Department of Pediatrics
Division of General Pediatrics
From Provisional Courtesy to
Provisional Active

Harry W. Stephens, MD
(Ne1 ~osurgical Associates, PC)

Additional Privileges
Brian L. Fellechner, DO
Department of Medicine
Division of Physical
Medicine/Rehabilitation
Provisional Active
EMG/NC P!wileges
D. Lynn Morris, MD
Department of Medicine
Division of Cardiology
Active
Transluminal Extraction Catheter
Atherectomy Rrivileges (TEC)

Kenneth P. ~\korinko, MD
Department of Medicine
Division of Cardiology
Active
EKG Reading Privileges
Intercoronary Stent Placement
Privileges

Appointment of New Division
Chief
Broce L Rot.:P.. MD
Chief, Divh2.
f Reproductive
Endocrinolog; ;:.,, Infertility
Department of Obstetrics and
Gynecology

De:!artment of Surgery
D1 vision of Neurosciences
From Active to Emeritus Active

Change of Address (Suite
Number)

Luke CK Yip, MD

Broce A. Ells'•,;>.tg, MD
Linda S. Loffn::do, MD
1251 S. Cedar Crest Blvd.
Suite 102A
Allentown, PA 18103

(Panebianco - Yip Heart Surgeons)

Department of Surgery
Division of Cardio-Thoracic Surgery
From Active to Emeritus Active

(Effective 8/1/94)

Continued on Page 17
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Practice Addition and Name
Change
Russell J. Rentler, MD has joined
Drs. Mishkin, Rappaport and Shore

The practice name has changed to:
Mishkin Rappaport Shore Rentler
Internal Medicine
Dr. Rentler will maintain his office in
Macungie

Allied Health
Professionals
Appointments
Beverly Baker, RN
Physician Extender
Professional - RN
(Children's Healtb.Care- Dr. Toff)

Danny Stein, PNP
Physician Extender
Professional - PNP
(Peds Clinic - Dr. Smith)

Resignation
Mary Konolige, CRNA
Physician Extender
Professional - CRNA
(Dr. Maffeo)
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P & T HIGHLIGHTS
The following action were taken at the June 13, 1994 Pharmacy and
Therapeutics Committee Meeting - James A. Giardina, Director of Pharmacy

FORMULARY ADDITIONS 4 YEAS AND A NAY
· Amino Acid Enriched Cardioplegia (AAEC)
is a variant of the traditional cardioplegia
intended to counteract the damaging effects
of reperfusion in patients with compromised
myocardium.
According to some
investigators,
amino acid containing
solutions serve to replenish essential krebs
cycle intermediates exhausted through the
processes of anaerobic metabolism during
ischemic intervals. While there has been
literature showing benefit in energy depleted
hearts, there is no current literature which
demonstrates signifi ·.· !lnt benefit in hearts
The
with adequate en v reserves.
of AAEC according
committee approved
ie 1. An ongoing
to criteria listed in
review will be condt .d to see if benefit is
seen relative to ch .reased critical care
hours, or other measL ;able positive impact.
These data will ag~;: '1 be presented to the
committee prior Li a decision on fuH
formulary status for this product.
Additionally these solutions may be
indicated for those patients who fail to wean
from CPB following a technically successful
open heart procedure. In such cases the
aorta should again be cross-clamped and a
second dose of cardioplegia administered.

:

:-

·-·-

..

Table 1: AAEC Usage Criteria
(one or more of the following conditions):
1.

2.
3.
4.

5.
6.

Acute myocardial infarction
(operated on within six hours of
infarct).
Cardiogenic shock.
Persistent angina with IABP support.
A"hythmic decompensation requiring
rapid extracorporeal circulation or
atrial and ventricular
tacyharrhythmias that are not
responsive to the usual
pharmacological or electrical
maneuvers.
Failed PTCA/thrombolytic therapy
requiring emergency surgery.
Prolonged CPB!cross - clamp times
expected:
prolonged L. 4 hrs of CPB
> 2 hrs of cross clamp; observation
of inadequate myocardial protection

Torsemide (Demadex, BM) is a sulfonylurea
loop diuretic indicated for treatment of
hypertension and edema associated with
CHF, cirrhosis or renal failure. Similarly to
the other loop diuretics, torsemide works
primarily in the thick ascending limb of the
Loop of Henle where it inhibits the sodium-
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potassium-2 chloride pump. Torsemide's
bioavailability is approximately 80%, with
little intersubject variation. It has little
first pass metabolism, and serum
concentration reaches peak within one hour.
Food delays absorption by about 30 minutes.
The elimination half life is approximately
3.5 hours, and it is cleared from the
circulation by both hepatic (80%) and renal
(20%) means. For all practical purposes,
metabolites are inactive. In patients with
decompensated CHF, clearance is reduced,
probably due to hepatic congestion and
reduced renal plasma flow, with a resultant
decrease in natruresis when compared to
normal subjects. In renal failure patients,
decreased renal clearance presents a smaller
fraction of the administered dose to the
intraluminal site of action, and the effect is
reduced.
Giving a higher dose will
compensate for this effect.
The diuretic
effects of torsemide begin within 10 minutes
of iv dosing and one hour with oral
administration.
Independent of route,
duration lasts from 6 - 8 hours. The usual
initial dose is 10 - 20mg daily for CHF;
5mg daily for hypertension: 20mg daily for
chronic renal failure; and 5- 10mg daily for
cirrhosis. Doses are generally escalated by
doubling until the desired response is
achieved. Single doses greater than 200mg
have not been studied and are not
recommended. Because of its excellent oral
bioavailability, oral and iv doses are
identical. Torsemide should not be given
concurrently with Cholestyramine
(Questran), and should be used cautiously in
patients receiving high dose salicylates,
lithium or aminoglycosides. Torsemide has
not been studied in pregnancy, nursing
females or children. The most common side
effects include headache, excessive
urination, and dizziness. Torsemide injection
was approved for iv push administration by
nurses to be given over 2 minutes. There is
no compatibility data available at this time, ·

therefore iv lines should be flushed with
saline before and after injection.
Torsemide comes in 5nig, 10mg, 20mg and
100mg tablets and 20mg and 50mg ampules;
it costs between 0. 03 - 0.10 per oral dose
and 0.20 - 30 per injectable dose. In
summary, torsemide appears to be a good
second choice to furosemide due to its 1: 1
IV to PO conversion, its long half life which
allows for once daily dosing, and its dual
elimination pathway. Given the apparent
advantages of torsemide, bumetanide
injection will be removed from the
formulary and bumetanide tablets will be
maintained for patients who are taking it on
admission.

~

Nedocromil (Tilade, Fisons) is an inhaled
anti-inflammatory agent used for the
preventative management of asthma. It
works by decreasing infiltration of
inflammatory cells into the airway.
Nedocromil is structurally dissimilar to
cromolyn, but appears to resemble it in its
action on mast cells. Both inhibit mast cells
degranulation, histamine & serotonin
release, with nedocromil appearing to be
more potent. Patients using nedocromil are
often able to decrease beta-2 agonists.
Following inhalation, 90% of the dose is
deposited in the throat & swallowed, where
3% is absorbed. In healthy volunteers, 79% reaches the lungs and is absorbed.
Lower amounts reach the ·lungs in asthmatic
patients. The usual dose is two puffs
(3.5mg) four times daily, with less frequent
administration possible for patients in good
control.
Nedocromil is not a bronchodilator and is
not indicated for acute bronchospasm. It
should be used regularly to achieve benefit,
and has been given with other anti-asthma
agents, which work by different
mechanisms. It has not been studied in
pregnancy, nursing females or children
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under 12. The most common side effect is
bitter taste. Sore throat, irritation, cough,
headache, N & V have also been reported.
Several studies suggest that nedocromil may
exert a slight steroid sparing effect, which
may be especially beneficial in adolescents.
Nedocromil is available in a 112 dose MDI
and is priced less than cromolyn. Cromolyn
will remain on the formulary for now as
nedocromil is unavailable in a solution form.
If. nedocromil lives up to its expected
benefit, cromolyn use is expected to drop.

Milrinone. lactate (PrimacorR, SanofiWinthrop) - .is a more potent derivative of
amrinone indicated for the short-term
therapy of CHF. Like amrinone, milrinone
has also been used in the treatment of low
cardiac output following (. •.rdiac surgery.
Milrinone exhibits inotropil .<. d vasodilatory
effr"·rs by blocking phospaodiesterase in
ca.-·
and vascular muscle. This results in
tm
::nent in cardiac output, pulmonary
cap~; ,, y wedge pressure, and peripheral
vascubr resistance. Milrinone is primarily
excrer :d unchanged in the urine (83%) and
becau~i,; of this, patients with severe renal
failure will have an extended half life from
2.3 hr to 3.24 hr and require lower infusion
rates. The most common adverse reactions
are ventricular arrhythmias, hypotension and
headache. Less common side effects include
angina,
hypokalemia, tremor, fever,
bronchospasm and thrombocytopenia.
· TABLE 2: Delivery Rates in Normal Renal Function

Milrinone's reported r;d;: of
thrombocytopenia is less thar
:;t of
amrinone, 0.4% compared tc 2.4%,
respectively.
Milrinone is physically
incompatible with furosemide (Lasix),
therefore furosemide injection should not be
given through an IV line containing
milrinone. Milrinone is compatible with
Dextrose (unlike amrinone).
Cardiac
function, renal function,· fluid statJs and
electrolytes, especially potassium, should be
monitored. Dosage adjustments should be
made on the basis of cardiac function
studies.
Milrinone is given as a loading dose of
50mcg/Kg infused slowly over 10 minutes
followed by a maintenance infusion of 0.375
to 0. 75mcg/Kg/min.
Table 2 shows
delivery rates in ml/Kg/hr for various
concentrations and infusion rates. Table 3
shows dosage adjustments for decreasing
creatinine clearances. Milrinone appears to
offer advantages over amrinone in its side
effect profile (thrombocytopenia) and cost
$144-384/day (Milrinone) vs $263-482/day
(Amrinone). Amrinone was deleted from
the formulary given the lack of need for two
agents in this class.
The standard concentration will be
lOOmcg/ml with the ability to double
concentrate to 200mcg/ml for fluid restricted
paitents.
TABLE 3: Infusion Rates in Renal Impairment

Milrinone Rates of Infusion
Infusion Delivery Rate'
Milrinonc:
(meg/kg/min)

IOOmcg/mf
(ml/kg/hr)

200mcg/ml'
(ml/kg/hr)

Milrinone Infusion Rate in lmpaired Rettal Function
Creatinine clearance
(ml/min/1.73 m')

Infusion rate
(meg/kg/min)

0.375

0.22

0.11

5

0.2

0.4

0.24

0.12

10

0.::!3

0.5

0.3

0.15

20

0.28
0.33

0.6

0.36

0.18

30

0.7

. 0.42

0.21

40

0.38

0.45

0.22

so

0.43

0.75

1 In order to calculate flow rate (mllhr), multiply infusion delivery
rate times. patient weight (in kg).
2 Prepare by adding 180m! diluent per 20mg vial (20m!).
3 Prepare by adding 80ml diluent per 20mg vial (20m!).
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MONO ONLY MEANS
ONE
FORMULARY
REJECTION
!sosorbide Mononitrate (lmdur, Schering)
ts a once daily version of this agent.
Currently, ISMO (Robins brand of ISMN) is
on the formulary. The committee felt that
the Schering product offered little benefit
over the Robins formulation and was more
It was rejected for these
expensive.
reasons.

FORMULARY DELETIONS
In addition to Amrinone, approximately 200
little used, non emergency agents were
deleted from the formulary.

Oxazepam (Serax, Wyeth) was approved at
least until the order sheets are revised.
All flurazepam orders· will be changed to
oxazepam 10 mg HS pm with a may repeat
once up till 3 AM order. Oxazepam is one
of the several oral benzodiazepines which
are intermediate in half life (3-20 hours)
without active metabolites. Flurazepam and
its active metabolite has a half life of 47-100
hours with possible prolongation in the
Other recommendations which
elderly.
were accepted included the placement of an
educational note on the charts of patients
over 65 who are prescribed chloral hydrate
(Noctec) or diphenhydramine (Benadryl) for
sleep. The reasons for these
recommendations are the lack of efficacy of
the former and the anticholinergic effects of
the latter. The proposal will take effect in
the fall. (no pun intended)

DRUG USE EVALUATION
(DUE) CORNER
DALMANE
FALL

TAKES

A

The committee accepted a series of
recommendations from the Geriatric
Division relative to hypnotic use. The
most significant recommendation is the total
removal of flurazepam (Dalmane, Roche)
from the formulary. The rationale for this
action is the relationship between use of
long acting sedative-hypnotic agents with
active metabolites and patient falls. Given
that flurazepam is listed on many preprinted
orders, an automatic substitution with

Target Antibiotics
Pharmacy presented a four month (JanuaryApril) report on total parenteral antibiotic
use and costs. Compared to 1993, costs for
February-April are lower, with fewer grams
used in March-April. Cost per Gram index
was also lower in February-April, which
indicates use of less expensive antibiotics.
Relative to the target antibiotics, length of
empiric therapy has decreased to less than
four days, and recommendations for
alternative therapies were accepted from 67100% of the time in April.
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Alteplase

(t~PA)

In May, 8 patients were treated with 6
receiving standard (STD) dosing and 2
receiving accelerated (ACCEL) dosing. One
(STD) patient experienced 'recurrent
ischemia, and two patients, one in each
group, experienced tamponades with bloody
effusions. 3 STD and both ACCEL patients
went on to further cardiac interventions.
The only patient under 65 K.g was weight
dosed (STD) accordingly.

Cisapride
A two montb 'ldy of cisapride prescribing
was presenteo w the committee, based on
the committee's recommendation at the time
of considering this age:_ t for formulary
addition.
17 patients had Cisapride therapy initiated
in-house while 10 patients were admitted on
Cisapride. Therapy was initiated during
hospitalization for gastroparesis (7 patients),
idiopathic N/V (5 patients), post chemo N/V
(1 patient), ileus (2 patients) and esophageal

stricture (2 patients). · uf 17 patl~nts were
started following a tr :ontraind~>;ations to
Metoclopramide, 3
c\ents experienced
diarrhea, and 2 pt ,Js had a possible
interaction with Waifarin. INR' s were
prolonged to > 9. A temporal relationship
was present, but other mechanisms were not
excluded.

DISCUSSION
DARVOCET N-100

ON

Darvocet N-100 is a commonly used
analgesic containing 100mg propoxyphene
and 650mg of acetaminophen in each r; 'ilet.
The acetaminophen content poses a ri~:t.. for
patients prescribed to receive many pm
meds containing acetaminophen. Results
were presented from a random survey on
one unit of the total potential acetaminophen
(APAP) dose available in a 24 hour period.
The maximum amount prescribed was
15.6g, if all doses would have been given.
No patient received more than 4g during any
24 hour period. The committee requested
that an Ad-Hoc group be formed to make
recommendations on reducing the potential
for excessive APAP doses.
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HEALTH NETWORK

LABORATORIES
A Service of lEHI@iVAU..EY
HOSPm\L

Before continuing with the newsletter
on screening tests for thyroid disease,
we have been requested to list the
testing scheduled for hormones and
macromolecules. The Clinical
Laboratory has been actively replacing
the labor intensive radioimmunoassay
RIA methodology with automated
non-isotopic immunoassay methods.
The most recent addition is a
chemiluminescence system which
measures the light emitted from a
premixed cocktail of reagents and
equates this light emission to a
concentration. Detection limits for
chemiluminescent reactions are in the
I0-18 to 10"21 range. This makes
possible ultrasensitive immunoassays,
especially two-site sandwich assays
where label detection is the principle
factor governing overall assay
sensitivity. A hormone assay which
we have recently offered employing
chemiluminescence is the 3rd
generation TSH with analytical
sensitivity to 0.004 ulu/ml.
A second major advantage of the nonisotopic automated methods is that their
calibration is stable for several weeks.
This means that they can be offered
more frequently (even STAT) and
more economically with decreased
usage of costly reagents.

The two hormone tests which can be
clinically justified as STAT requests
are T4 and Cortisol especially for
patients exposed to the stress of
surgery.
Thyrotoxicrisis (Thyroid Storm) is an
acute exacerbation of all symptoms of
thyrotoxicosis which may present as a
syndrome of life-threatening severity.
Acute adrenal crisis represents a state
of acute adrenocortical insufficiency
and occurs in patients with Addisons
Disease who are exposed to the stress
of infection, trauma, dehydration or
surgery. T4 and Cortisol now can be
requested STAT from the Toxicology
Division at Ext. 2578.
The regular testing schedule is listed
below with the tests above the line
being done in toxicology and those
below the line in Immunology. Both
laboratory sections are at the 17th &
Chew site with Toxicology being
staffed 24 hours/day, 7 days/week.

Gerald E. Clement, Ph.D.
Technical Director
Clinical Laboratories
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TESTING SCHEDULE

Monday
Ff4
T4-TBI (T7)
TSH
LH-FSH
Cortisol
Prolactin
BHCG
IPTH
PSA

Tuesday

T4-TBI (T7)
TSH

BHCG

PSA

Wednesday
Fr4
T4-TBI (T7)
TSH
LH-FSH
Cortisol
Prolactin
BHCG
IPTH
PSA
PAP

B12-Folate
Ferritin
CEA

Thursday

T4-TBI (T7)
TSH

BHCG

PSA

Friday
Fr4
T4-TBI (T7)
TSH
LH-FSH
Cortisol
Prolactin
BHCG
IPTH

Saturday/
Sunday
T4-TBI (1'7)
TSH

BHCG

PSA

B12-Folate
Ferritin
CEA
Tumor
Markers
Prenatal
Triscreen

Testosterone
T3
Prenatal
Triscreen
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The Decision-Making Matrix: Defining
Board And Administrative Roles
Lehigh Valley Health Network has developed a decision-making matrix that clarifies the roles
and responsibilities of the organization's governing board and administration. The matrix
incorporates the recommendations of health network trustees and members of the senior
management council who met to discuss governance issues and functional planning during a
retreat in June.
The Board of Trustees will continue to set policy and provide brdad direction for the hospital
while the Chief Executive Officer and Senior Management Council will retain responsibility for
recommending and managing policy development, strategies to achieve specific goals and
overall operations (as outlined in the accompanying columns and charts.)
The Senior Management Council reports to the
President and Chief Executive Officer of the
organization who also serves on the council.
Other members of the council include the:

Senior Management Council Responsibilities
and Functions

• Chief Operating Officer
• Senior Vice President & Chief Information Officer

• Provides organizational focus to the Board
of Trustees of the Lehigh Valley Health
Network/Lehigh Valley Hospital.

• Senior Vice President, Lehigh Valley Health
Services

• Clarifies and filters organizational issues to
appropriate personnel.

• Senior Vice President, Clinical Services
• Vice President, Marketing & Planning

• Ensures that organizational policy, direction, decisions, and operations fu1:611 the
organization's mission and vision.

• Executive Director, lehigh Valley Physician Group

• Develops strategy and policy direction.

• President. Medical Staff

• Identifies and sets standards that define
organizational culture.

• Senior Vice President & Chief Financial Officer

)

• Senior Vice President, Patient Care Services

• President-Elect. Medical Staff
• Past-President. Medical Staff
• Chairman, Department of Medicine
• Chairman, Department of OB/GYN
• Chairman, Department of Pediatrics
• Chairman, Department of Psychiatry
• Chairman, Department of Surgery
• Chairman, Department of Emergency Medicine
• Chairman, Department of Anesthesiology
• Chairman, Department of Radiology/Diagnostic
Medical Imaging

)

• Chairman, Department of Pathology
• Chairman, Department of Family Medicine

• Represents and is responsible to the Board
ofTrustees for entire organization

Guideline for The Decision-Making Process
Effective decision-making is central to the
Senior Management Council and is guided ·
by the following organizational principles:

Council members are expected to make
decisions in response to the best interests of
the patient and the organization in general,
given available resources.
Every member has input or decision-making
responsibility depending on the individuals
role on an issue. Choosing the appropriate
role on an issue is expected of everyone.
However, the right to have input is different
from the responsibility to make a decision.
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Management requires measurement. Decision-making should be made and monitored
using the best information and measurement
available.
Disagreement about proposals must be
communicated constructively and directed
toward processes and requirements, not
persons.
After a decision is made, it must be supported. Appeals will be reviewed subject to
appropriate sponsorship.
In order to strengthen management skills
and the decision-making process, all managers are expected to pursue continuing
education of management processes and
techniques.
The Decision-Making Diagram: Definitions
and Explanations

Governance is setting the broad direction for
the organization, including policy. Managers
can develop policy for areas for which they
are responsible, but they must be consistent
with the board's policies.
Additional definitions include:
Administrative - Those issues primarily

focused on the operations and general
management of: ::e hospit:ll. They include
staffing, financial management, program
decisions, building and plant issues, efficiency and effectiveness of the organization.

Clinical- Those issues primarily focused on
the delivery of medical services to patients,
including effectiveness and efficiency of
. treatment, development of new programs,
education and evaluation of performance of
clinicians. (Credentialing and quality assessment of caregivers are the prerogative of the
board with coordination' through medical
staff processes via the medical executive
committee and clinical chairs.)
Strategy- A plan of action for achieving goals.

Tactics - The steps required to accomplish a

specific goal.
Operations .. The structure and process
required to complete specific tasks - carrying
outwork.

1 .: ~i·,m- Hospital division, Lehigh Valley

l.
1 Services Division, Lehigh Valley
Phy . 1ans Group and/or any individual who
reportS to the CEO and is a member of
Senior Management Council.
Deparbllent - .Operating unit led by clinical
chairman, vice presic::nt, group manager, or
administrator.

Unit - Operating unit organized around a

specific function, i.e., a nursing unit, clinical
division (such as cardiology), laboratory
section, Health Spectrum Pharmacy Services,
etc.
The remainder of the chart moves decisionmaking to the most appropriate level within
the organization. Each block in the diagram
suggests the organizational level for decisions
that are in general concert with the
organization~ broad direction and policies.
Anytime there are two or more names in a
block, the type of decision will determine the
appropriate decision-maker and the role of
the others listed. For instance, the President
will look to the Senior Management Council
for some decisions; others he will make, often
with input from Senior Management Council. It will be ultimately the President~
responsibility as to which decisions are
brought to the Senior Management Council
and for what purpose: 1) information,
2) advice and consultation, or 3) decisionmaking.
Each member of the Senior Management
Council can make strategy and tactical
decisions at a divisional level, depending on
the cross-functional aspects and implications
of the decisions.
No governance issues will be decided at the
departmental or unit level. These are reserved
for higher organizational levels.
Operational issues are always assigned to the
lowest responsible level in the organization
for decision-making. Under the unit definition, the appropriate decision maker could be
a section chief, the head of a clinical division,
or a unit manager.•
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Organizational Decision Making Responsibility

ADMINISTRATIVE/CLINICAL ISSUES

Clinical Chair/

CEO/SMC

I CEO/Division Head/SMC

I Department Head

I Division Head

I Department Head

I

I

Tactics

I

CEO/SMC

Operations

I

to Division

to Department

Clinical Chair/

........

Section Chief/
Unit Manager
Section Chief/

to Unit

I Unit Manager

N. B. Credentialing and quality assessment of physicians and other practitioners are the prerogative of the Board with coordination
through medical staff processes via the Medical Executive Committee and Clinical Chairs.
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is published monthly to
inform the Lehigh Valley
Hospital Medical Staff and
employees of important issues
concerning the Medical Staff.
Artides should be submitted
to Janet M. Laudenslager,
Physician Relations, 1243 S.
Cedar Crest Boulevard,
Allentown, PA 18103, by the
rmt of each month. If you
have any questions about the
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Laudenslager at 402-9853.
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